Profit after tax came in ₹38.4 crore in Q2 of FY25, a recovery from a net loss of ₹11.8 crore in the first quarter of this fiscal. The shares of AstraZeneca Pharma India ended 1.7% in the green on Wednesday, November 13.
Share it
Open an Account in less than 1 Min.
Need help? Call us
+91 888 718 7394
Services
Company
Get in touch
- +91 888 718 7394
- info@markettrade.live
- Pjazza Mifsud Bonnici, Marsascala, Malta
- 333, Pali Pathar, Khar West, Mumbai, Maharashtra 400052
Copyright © 2025 Market Trade